Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)

Autor:	Rodolfo Passalacqua, Giovanni L. Pappagallo, Sandro Pignata, Pierangela Sepe, Sergio Bracarda, Stefania Gori, Maria Giuseppa Vitale, Rodolfo Montironi, Franco Nolè, Alberto Lapini, Alberto Mandressi, Giuseppe Di Lorenzo, Luigia Romano, Giuseppe Procopio, Giario Conti, Camillo Porta, Giuseppe Martorana, Cristina Masini, Guido Martignoni, Laura Cosmai, Emanuele Crocetti, Michele Guida, Giacomo Cartenì, Cinzia Ortega
Rok vydání:	2019
Předmět:	recommendation Oncology Cancer Research medicine.medical_specialty Evidence-based practice Italian VEGF receptors Kidney metastasis 030232 urology & nephrology renal cell cancer urologic and male genital diseases Medical Oncology Kidney tumor Cancer prognosis 03 medical and health sciences 0302 clinical medicine Renal cell carcinoma Internal medicine medicine Carcinoma Humans guidelines Carcinoma Renal Cell biology business.industry General Medicine medicine.disease Kidney Neoplasms AIOM Italy 030220 oncology & carcinogenesis biology.protein business Kidney cancer
Zdroj:	Tumori. 105(4_suppl)
ISSN:	2038-2529
Popis:	In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncology (AIOM) Renal Cell Cancer (RCC) Guidelines Panel has developed clinical guidelines to provide evidence-based information and recommendations to oncologists, urologists and all professionals involved in the management of patients with renal cell cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cadcadf4a6fe7c2a4bce69a9cfe9d5c https://pubmed.ncbi.nlm.nih.gov/31264522 Zobrazit plný text záznamu